- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Parnax Lab Ltd manufactures and exports Pharmaceutical FormulationsBusiness Overview: PLL is a part Naxpar Group and is a WHO-approved and EHS-compliant Company. It is into contract manufacturing of Liquid Orals, Capsules, Ointments, External Powders & Tablets with its manufacturing facility located at Silvassa.
Parnax Lab has announced the closure of its share transfer books from September 23 to September 29 in preparation for its 44th Annual General Meeting, scheduled for September 29. A record date of September 22 has been established to determine shareholder eligibility for e-voting. Shareholders can cast their votes electronically...
Parnax Lab's board has approved the financial results for the quarter, reporting standalone revenue of 2.56 Cr and a profit of 0.85 Cr. Consolidated revenue stood at 56.80 Cr with a profit of 0.43 Cr. The company has announced its 44th Annual General Meeting will be held on September 29....